Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

pseudohypoparathyroidism/offita

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 106 niðurstöður
BACKGROUND Pseudohypoparathyroidism type Ia and pseudopseudohypoparathyroidism are characterized by Albright's hereditary osteodystrophy (AHO), respectively, with and without hormone resistance. Both clinical conditions result from decreased expression or function of the alpha-subunit of the

Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND Children with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. These children have decreased resting energy expenditure but it is unknown if hyperphagia contributes to their obesity. METHODS We conducted a survey assessment of patients 2 to 12 years old with PHP-1a

Early manifestation of obesity and calcinosis cutis in infantile pseudohypoparathyroidism.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Pseudohypoparathyroidism is a parathyroid hormone resistance condition, characterised by biochemical findings of hypocalcaemia or normocalcaemia with inappropriately elevated parathyroid hormone level and usually with a typical osteodystrophy feature. We report an infant with

Pseudohypoparathyroidism--another monogenic obesity syndrome.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Obesity is a common feature of pseudohypoparathyroidism (PHP) type 1a, but is usually associated with short stature. We describe two children referred because of hyperphagia and excessive weight gain from early infancy. Tall stature in both children initially confounded the diagnosis of PHP, but on

Energy expenditure in obese children with pseudohypoparathyroidism type 1a.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND Patients with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. The abnormality in energy expenditure and/or energy intake responsible for this weight gain is unknown. OBJECTIVE The aim of this study was to evaluate energy expenditure in children with PHP-1a compared

Defective stimulation of adipocyte adenylate cyclase, blunted lipolysis, and obesity in pseudohypoparathyroidism 1a.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Adipocyte plasma membranes were isolated from four patients with type 1a pseudohypoparathyroidism, a disease in which deficiency of the stimulatory guanine nucleotide binding protein Gs has been reported, and from controls. Stimulation of adenylate cyclase by isoproterenol was defective, whereas

Pseudohypoparathyroidism type 1A and morbid obesity in infancy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
OBJECTIVE To describe an infant with early excessive weight gain as the principle manifestation of pseudohypoparathyroidism (PHP) type 1a and Albright hereditary osteodystrophy (AHO). METHODS We describe the clinical and laboratory findings in an infant with early excessive weight gain without
BACKGROUND Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein alpha-subunit Galpha(s). Because Galpha(s) is paternally imprinted in certain hormone target tissues, maternal inheritance of

Obesity and calcinosis cutis: characteristic early signs of infantile pseudohypoparathyroidism.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Pseudo-pseudohypoparathyroidism: report of a case with associated cardiopulmonary syndrome of obesity.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Pseudohypoparathyroidism, obesity, and type 2 diabetes. A hypothesis.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Identification of a novel mutation in a pseudohypoparathyroidism family.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Pseudohypoparathyroidism type Ia (PHP Ia) is defined as a series of disorders characterized by multihormone resistance in end-organs and Albright hereditary osteodystrophy (AHO) phenotype. PHP Ia is caused by heterozygous inactivating mutations in GNAS, which encodes the stimulatory G-protein alpha

Classic and Non-Classic Features in Pseudohypoparathyroidism: Case Study and Brief Literature Review.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Pseudohypoparathyroidism is a rare condition that is due to a defect in the stimulatory G-protein coupled receptor, resulting in end-organ resistance to parathyroid hormone. Hereditary forms of pseudohypoparathyroidism present with certain classic features such as obesity, short stature,

Spinal cord compression in pseudohypoparathyroidism.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND Spinal cord compression associated with pseudohypoparathyroidism (PHP) is an increasingly reported sequelae of the underlying metabolic syndrome. The association of neurologic dysfunction with PHP is not well appreciated. We believe this to be secondary to a combination of underlying

What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Pseudohypoparathyroidism (PHP) is a rare disease whose phenotypic features are rather difficult to identify in some cases. Thus, although these patients may present with the Albright's hereditary osteodystrophy (AHO) phenotype, which is characterized by small stature, obesity with a rounded face,
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge